Alps Advisors Inc Epizyme, Inc. Transaction History

Alps Advisors Inc

$14.5 Billion
Q2 2024

Shares

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2020 Feb 03, 2021	SELL	$10.34 - $13.77 $1.34 Million - $1.78 Million	-129,409 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$11.73 - $16.25 $99,083 - $137,263	-8,447 Reduced 6.13%	129,409 $1.54 Million
Q2 2020 Aug 05, 2020	SELL	$13.68 - $20.46 $379,195 - $567,130	-27,719 Reduced 16.74%	137,856 $2.21 Million
Q1 2020 May 06, 2020	SELL	$14.83 - $26.72 $264,107 - $475,856	-17,809 Reduced 9.71%	165,575 $2.57 Million
Q4 2019 Feb 07, 2020	BUY	$9.77 - $24.6 $17,918 - $45,116	1,834 Added 1.01%	183,384 $4.51 Million
Q3 2019 Nov 04, 2019	SELL	$10.17 - $13.86 $87,207 - $118,849	-8,575 Reduced 4.51%	181,550 $1.87 Million
Q2 2019 Aug 07, 2019	BUY	$11.43 - $15.12 $2.17 Million - $2.87 Million	190,125 New	190,125 $2.39 Million
Q4 2018 Feb 04, 2019	SELL	$5.22 - $10.44 $642,018 - $1.28 Million	-122,992 Closed	0 $0
Q3 2018 Oct 25, 2018	BUY	$9.5 - $13.75 $210,425 - $304,562	22,150 Added 21.97%	122,992 $1.3 Million
Q2 2018 Aug 02, 2018	BUY	$12.85 - $18.45 $309,286 - $444,073	24,069 Added 31.35%	100,842 $1.37 Million
Q2 2018 Jul 25, 2018	SELL	$12.85 - $18.45 $207,540 - $297,985	-16,151 Reduced 17.38%	76,773 $964,000
Q1 2018 May 01, 2018	BUY	$12.5 - $19.75 $201,887 - $318,982	16,151 Added 21.04%	92,924 $1.65 Million
Q4 2017 Feb 05, 2018	BUY	$11.55 - $20.1 $222,926 - $387,950	19,301 Added 33.58%	76,773 $964,000
Q3 2017 Nov 03, 2017	BUY	$12.7 - $19.25 $729,894 - $1.11 Million	57,472	57,472 $1.1 Million

About Epizyme, Inc.

Ticker EPZM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 168,364,992
Market Cap $247M

More about EPZM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.